LS
Lauren Stival Hopfer
Executive Director of Investor RelationsMs. Lauren Stival Hopfer is Executive Director of Investor Relations of enGene Therapeutics Inc. She was Managing Director of Stern Investor Relations, Inc. She was Vice President of Stern Investor Relations, Inc. She served as Senior Director of Investor Relations and Corporate Communications at Avadel Pharmaceuticals plc until December 2018. She holds Bachelor of Arts from Duke University.
Positions
- Company NameenGene Therapeutics Inc.Stock CodeENGNPositionExecutive Director of Investor RelationsRelated SecuritiesColleagues
- RHRonald H. W. CooperPresident, CEO & Director
- MTMichael Thomas HeffernanIndependent Non-Executive Chairman
- KRKathleen RichtonSenior VP of Finance, Principal Accounting & Financial Officer and Controller
- JCJoan ConnollyChief Technology Officer
- JGJason G. DuncanChief Legal & Administrative Officer
- PDPaul D. RobbinsChairman of Scientific Advisory Board
- LSLota S. ZothIndependent Non-Executive Director
- WSWouter Sebastian Johannes JoustraIndependent Non-Executive Director
